Summary

US Mobile Cardiac Telemetry Systems Market is valued approximately USD 310.13 million in 2023 and is anticipated to grow with a healthy growth rate of more than 13.19% over the forecast period 2024-2032. Mobile Cardiac Telemetry (MCT) systems are wearable devices that are used to constantly monitor a person's heart activity over extended period of time in order to identify abnormal rhythms and other cardiac events. Healthcare professionals receive data from these small devices wirelessly and examine it for anomalies. MCT systems provide real-time monitoring and prompt patient treatments, making them essential for the diagnosis and treatment of cardiac diseases including atrial fibrillation. The increase in remote patient monitoring is a key trend that is supporting the growth of the US Mobile Cardiac Telemetry Systems Market at a substantial rate. There is a significant increase in the adoption of remote patient monitoring solutions, including mobile cardiac telemetry systems. This trend is driven by factors such as the need for continuous heart monitoring, especially among elderly and high-risk patients, and the expansion of telehealth services.

In the US, heart disease continues to be the primary cause of mortality. An aging population, physical inactivity, and obesity are some of the major contributing factors. MCT systems are a useful tool for ongoing observation and early identification of various illnesses, which lowers mortality and consequence rates. Factors such as an expanding elderly population, a higher occurrence of cardiac disorders, and a surge in healthcare expenditure are the key driving factors for the US Mobile Cardiac Telemetry Systems Market growth. Also, favorable reimbursement policies from government and private payers, coupled with the shift towards patient-centric care models, contribute to the increasing integration of MCT systems into healthcare practices, thereby fueling market growth in the US. Moreover, the market is poised for expansion due to the active involvement of major service providers offering enhanced healthcare solutions during the forecast period. However, strict regulatory rules, quality control requirements, and a lack of professional training and education are likely hampering market growth throughout the forecast period of 2024–2032.


Major market player included in this report are:
BioTelemetry, Inc.
Biotricity Inc.
Applied Cardiac Systems Inc.
Company 4
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10


The detailed segments and sub-segment of the market are explained below:

By Application
Lead based
Patch Based

By End-use
Hospitals
Cardiac centers
Others


Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032

Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and Country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market

ページTOPに戻る

Table of Contents

Chapter 1. US Mobile Cardiac Telemetry Systems Market Definition and Research Assumptions
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates

Chapter 2. Executive Summary
2.1. US Mobile Cardiac Telemetry Systems Market Size & Forecast (2022- 2032)
2.2. Segmental Summary
2.2.1. By Application
2.2.2. By End-use
2.3. Key Trends
2.4. Recession Impact
2.5. Analyst Recommendation & Conclusion
Chapter 3. US Mobile Cardiac Telemetry Systems Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
Chapter 4. US Mobile Cardiac Telemetry Systems Market: Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. US Mobile Cardiac Telemetry Systems Market Size & Forecasts by Application 2022-2032
5.1. Lead based
5.2. Patch Based
Chapter 6. US Mobile Cardiac Telemetry Systems Market Size & Forecasts by End-use 2022-2032
6.1. Hospitals
6.2. Cardiac centers
6.3. Others
Chapter 7. Competitive Intelligence
7.1. Key Company SWOT Analysis
7.1.1. Company 1
7.1.2. Company 2
7.1.3. Company 3
7.2. Top Market Strategies
7.3. Company Profiles
7.3.1. BioTelemetry, Inc.
7.3.1.1. Key Information
7.3.1.2. Overview
7.3.1.3. Financial (Subject to Data Availability)
7.3.1.4. Product Summary
7.3.1.5. Market Strategies
7.3.2. Biotricity Inc.
7.3.3. Applied Cardiac Systems Inc.
7.3.4. Company 4
7.3.5. Company 5
7.3.6. Company 6
7.3.7. Company 7
7.3.8. Company 8
7.3.9. Company 9
7.3.10. Company 10
Chapter 8. Research Process
8.1. Research Process
8.1.1. Data Mining
8.1.2. Analysis
8.1.3. Market Estimation
8.1.4. Validation
8.1.5. Publishing
8.2. Research Attributes